1	Role	Role	B-NP	NN	O	0	ROOT	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	telomeres	telomere	B-NP	NNS	O	2	PMOD	0
4	in	in	B-PP	IN	O	1	NMOD	0
5	vascular	vascular	B-NP	JJ	O	6	NMOD	0
6	senescence	senescence	I-NP	NN	O	4	PMOD	0
7	.	.	O	.	O	1	P	0

1	Telomeres	Telomere	B-NP	NNS	O	2	SUB	0
2	are	be	B-VP	VBP	O	0	ROOT	0
3	DNA	DNA	B-NP	NN	B-DNA	4	NMOD	0
4	regions	region	I-NP	NNS	I-DNA	2	PRD	0
5	composed	compose	B-VP	VBN	O	4	NMOD	0
6	of	of	B-PP	IN	O	5	VMOD	0
7	TTAGGG	TTAGGG	B-NP	NN	B-DNA	8	NMOD	0
8	repeats	repeat	I-NP	NNS	I-DNA	6	PMOD	0
9	that	that	B-NP	WDT	O	8	NMOD	0
10	are	be	B-VP	VBP	O	9	SBAR	0
11	located	located	B-ADJP	JJ	O	10	PRD	0
12	at	at	B-PP	IN	O	11	AMOD	0
13	the	the	B-NP	DT	O	14	NMOD	0
14	ends	end	I-NP	NNS	O	12	PMOD	0
15	of	of	B-PP	IN	O	14	NMOD	0
16	chromosomes	chromosome	B-NP	NNS	B-DNA	15	PMOD	0
17	.	.	O	.	O	2	P	0

1	Specific	Specific	B-NP	JJ	O	2	NMOD	0
2	proteins	protein	I-NP	NNS	O	3	SUB	0
3	associate	associate	B-VP	VBP	O	0	ROOT	0
4	with	with	B-PP	IN	O	3	VMOD	0
5	the	the	B-NP	DT	O	6	NMOD	0
6	telomeres	telomere	I-NP	NNS	O	4	PMOD	0
7	and	and	O	CC	O	3	VMOD	0
8	form	form	B-VP	VB	O	3	VMOD	0
9	non-nucleosomal	non-nucleosomal	B-NP	JJ	B-protein	11	NMOD	0
10	DNA-protein	DNA-protein	I-NP	JJ	I-protein	11	NMOD	0
11	complexes	complex	I-NP	NNS	I-protein	8	OBJ	0
12	that	that	B-NP	WDT	O	11	NMOD	0
13	serve	serve	B-VP	VBP	O	12	SBAR	0
14	as	as	B-PP	IN	O	13	VMOD	0
15	protective	protective	B-NP	JJ	O	16	NMOD	0
16	caps	cap	I-NP	NNS	O	14	PMOD	0
17	for	for	B-PP	IN	O	16	NMOD	0
18	the	the	B-NP	DT	O	19	NMOD	0
19	chromosome	chromosome	I-NP	NN	B-DNA	17	PMOD	0
20	ends	end	B-VP	VBZ	O	3	VMOD	0
21	.	.	O	.	O	3	P	0

1	There	There	B-NP	EX	O	2	SUB	0
2	is	be	B-VP	VBZ	O	0	ROOT	0
3	accumulating	accumulate	I-VP	VBG	O	4	NMOD	0
4	evidence	evidence	B-NP	NN	O	2	PRD	0
5	that	that	B-SBAR	IN	O	4	NMOD	0
6	progressive	progressive	B-NP	JJ	O	8	NMOD	0
7	telomere	telomere	I-NP	NN	O	8	NMOD	0
8	shortening	shortening	I-NP	NN	O	9	SUB	0
9	is	be	B-VP	VBZ	O	5	SBAR	0
10	closely	closely	B-ADJP	RB	O	11	AMOD	0
11	related	related	I-ADJP	JJ	O	9	PRD	0
12	to	to	B-PP	TO	O	11	AMOD	0
13	cardiovascular	cardiovascular	B-NP	JJ	O	14	NMOD	0
14	disease	disease	I-NP	NN	O	12	PMOD	0
15	.	.	O	.	O	2	P	0

1	For	For	B-PP	IN	O	7	VMOD	0
2	example	example	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	7	P	0
4	vascular	vascular	B-NP	JJ	O	6	NMOD	0
5	cell	cell	I-NP	NN	O	6	NMOD	0
6	senescence	senescence	I-NP	NN	O	7	SUB	0
7	has	have	B-VP	VBZ	O	19	VMOD	0
8	been	be	I-VP	VBN	O	7	VC	0
9	reported	report	I-VP	VBN	O	8	VC	0
10	to	to	I-VP	TO	O	11	VMOD	0
11	occur	occur	I-VP	VB	O	9	VMOD	0
12	in	in	B-PP	IN	O	11	VMOD	0
13	human	human	B-NP	JJ	O	15	NMOD	0
14	atherosclerotic	atherosclerotic	I-NP	JJ	O	15	NMOD	0
15	lesions	lesion	I-NP	NNS	O	12	PMOD	0
16	and	and	O	CC	O	19	VMOD	0
17	this	this	B-NP	DT	O	18	NMOD	0
18	change	change	I-NP	NN	O	19	SUB	0
19	is	be	B-VP	VBZ	O	0	ROOT	0
20	associated	associate	I-VP	VBN	O	19	VC	0
21	with	with	B-PP	IN	O	20	VMOD	0
22	telomere	telomere	B-NP	NN	O	23	NMOD	0
23	shortening	shortening	I-NP	NN	O	21	PMOD	0
24	.	.	O	.	O	19	P	0

1	Impairment	Impairment	B-NP	NN	O	5	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	telomere	telomere	B-NP	NN	O	4	NMOD	0
4	integrity	integrity	I-NP	NN	O	2	PMOD	0
5	causes	cause	B-VP	VBZ	O	0	ROOT	0
6	vascular	vascular	B-NP	JJ	O	7	NMOD	0
7	dysfunction	dysfunction	I-NP	NN	O	5	OBJ	6	dysfunction
8	,	,	O	,	O	7	P	0
9	which	which	B-NP	WDT	O	7	NMOD	0
10	is	be	B-VP	VBZ	O	9	SBAR	0
11	prevented	prevent	I-VP	VBN	O	10	VC	18	prevented
12	by	by	B-PP	IN	O	11	VMOD	0
13	the	the	B-NP	DT	O	14	NMOD	0
14	activation	activation	I-NP	NN	O	12	PMOD	17	activation
15	of	of	B-PP	IN	O	14	NMOD	0
16	telomerase	telomerase	B-NP	NN	B-protein	15	PMOD	0
17	.	.	O	.	O	5	P	0

1	Mice	Mouse	B-NP	NNS	O	5	SUB	0
2	with	with	B-PP	IN	O	1	NMOD	0
3	short	short	B-NP	JJ	O	4	NMOD	0
4	telomeres	telomere	I-NP	NNS	O	2	PMOD	0
5	develop	develop	B-VP	VBP	O	0	ROOT	0
6	hypertension	hypertension	B-NP	NN	O	5	OBJ	0
7	and	and	O	CC	O	5	VMOD	0
8	exhibit	exhibit	B-VP	VBP	O	5	VMOD	0
9	impaired	impaired	B-NP	JJ	O	10	NMOD	0
10	neovascularization	neovascularization	I-NP	NN	O	8	OBJ	3	neovascularization
11	.	.	O	.	O	5	P	0

1	Short	Short	B-NP	JJ	O	2	NMOD	0
2	telomeres	telomere	I-NP	NNS	O	3	SUB	0
3	have	have	B-VP	VBP	O	0	ROOT	0
4	also	also	I-VP	RB	O	3	VMOD	0
5	been	be	I-VP	VBN	O	3	VC	0
6	reported	report	I-VP	VBN	O	5	VC	0
7	in	in	B-PP	IN	O	6	VMOD	0
8	the	the	B-NP	DT	O	9	NMOD	0
9	leukocytes	leukocyte	I-NP	NNS	B-cell_type	7	PMOD	0
10	of	of	B-PP	IN	O	9	NMOD	0
11	patients	patient	B-NP	NNS	O	10	PMOD	0
12	with	with	B-PP	IN	O	11	NMOD	0
13	cardiovascular	cardiovascular	B-NP	JJ	O	14	NMOD	0
14	disease	disease	I-NP	NN	O	19	NMOD	0
15	or	or	O	CC	O	19	NMOD	0
16	various	various	B-NP	JJ	O	19	NMOD	0
17	cardiovascular	cardiovascular	I-NP	JJ	B-protein	19	NMOD	0
18	risk	risk	I-NP	NN	I-protein	19	NMOD	0
19	factors	factor	I-NP	NNS	I-protein	12	PMOD	0
20	.	.	O	.	O	3	P	0

1	Although	Although	B-SBAR	IN	O	17	VMOD	0
2	it	it	B-NP	PRP	O	3	SUB	0
3	remains	remain	B-VP	VBZ	O	1	SBAR	0
4	unclear	unclear	B-ADJP	JJ	O	3	PRD	0
5	whether	whether	B-SBAR	IN	O	3	VMOD	0
6	short	short	B-NP	JJ	O	7	NMOD	0
7	telomeres	telomere	I-NP	NNS	O	9	SUB	0
8	directly	directly	B-ADVP	RB	O	9	VMOD	0
9	cause	cause	B-VP	VB	O	5	SBAR	0
10	cardiovascular	cardiovascular	B-NP	JJ	O	11	NMOD	0
11	disease	disease	I-NP	NN	O	9	OBJ	0
12	,	,	O	,	O	17	P	0
13	manipulation	manipulation	B-NP	NN	O	17	SUB	0
14	of	of	B-PP	IN	O	13	NMOD	0
15	telomere	telomere	B-NP	NN	O	16	NMOD	0
16	function	function	I-NP	NN	O	14	PMOD	0
17	is	be	B-VP	VBZ	O	0	ROOT	0
18	potentially	potentially	B-ADVP	RB	O	17	VMOD	0
19	an	an	B-NP	DT	O	21	NMOD	0
20	attractive	attractive	I-NP	JJ	O	21	NMOD	0
21	strategy	strategy	I-NP	NN	O	17	PRD	0
22	for	for	B-PP	IN	O	21	NMOD	0
23	the	the	B-NP	DT	O	24	NMOD	0
24	treatment	treatment	I-NP	NN	O	22	PMOD	0
25	of	of	B-PP	IN	O	24	NMOD	0
26	vascular	vascular	B-NP	JJ	O	27	NMOD	0
27	senescence	senescence	I-NP	NN	O	25	PMOD	0
28	.	.	O	.	O	17	P	0

